Safety and Tolerability of Gefapixant (MK-7264) in Participants With Obstructive Sleep Apnea (MK-7264-039)

NCT03882801 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Obstructive Sleep Apnea (OSA)

Interventions

DRUG: Gefapixant
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC